Qiagen Gestione
Gestione criteri di controllo 4/4
Qiagen Il CEO è Thierry Bernard, nominato in Oct2019, e ha un mandato di 5.08 anni. la retribuzione annua totale è $ 1.99M, composta da 49.1% di stipendio e 50.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.14% delle azioni della società, per un valore di $ 13.52M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.8 anni e 9.6 anni.
Informazioni chiave
Thierry Bernard
Amministratore delegato
US$2.0m
Compenso totale
| Percentuale dello stipendio del CEO | 49.1% |
| Mandato del CEO | 5.1yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | 6.8yrs |
| Durata media del Consiglio di amministrazione | 9.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Some Confidence Is Lacking In Qiagen N.V.'s (NYSE:QGEN) P/S
Oct 11
An Intrinsic Calculation For Qiagen N.V. (NYSE:QGEN) Suggests It's 32% Undervalued
Sep 24With Qiagen N.V. (NYSE:QGEN) It Looks Like You'll Get What You Pay For
May 21Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
May 03Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly
Mar 20Calculating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)
Feb 13Qiagen N.V.'s (NYSE:QGEN) Price Is Out Of Tune With Earnings
Jan 23These 4 Measures Indicate That Qiagen (NYSE:QGEN) Is Using Debt Reasonably Well
Dec 08An Intrinsic Calculation For Qiagen N.V. (NYSE:QGEN) Suggests It's 41% Undervalued
Oct 24Qiagen: No Upsides Slated In FY'23 In Core Business Lines, Reiterate Hold
Sep 09Qiagen (NYSE:QGEN) Seems To Use Debt Quite Sensibly
Sep 04Calculating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Jul 17Qiagen: Major Asset Growth Needed In Post-Covid World
Jun 22Is Qiagen (NYSE:QGEN) Using Too Much Debt?
May 23Calculating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Apr 18Qiagen (NYSE:QGEN) Seems To Use Debt Quite Sensibly
Feb 15Qiagen: Strong Q4, Derisked Portfolio, Fairly Valued
Feb 14Qiagen Non-GAAP EPS of $0.53, revenue of $498M, FY23 guidance initiated
Feb 07If EPS Growth Is Important To You, Qiagen (NYSE:QGEN) Presents An Opportunity
Jan 18Qiagen, Helix partner to advance NGS companion diagnostics in hereditary diseases
Jan 06A Look At The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Jan 04Qiagen's test gets FDA nod for companion diagnostic to Mirati's cancer drug Krazati
Dec 13Qiagen Non-GAAP EPS of $0.53 beats by $0.08, revenue of $500M beats by $17.91M
Nov 07We Think Qiagen (NYSE:QGEN) Can Stay On Top Of Its Debt
Oct 31Qiagen stock down after BHF downgrades rating to Neutral
Oct 10Calculating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Oct 04Qiagen to develop companion diagnostic for Neuron23's Parkinson's disease drug candidate
Sep 14Does Qiagen (NYSE:QGEN) Deserve A Spot On Your Watchlist?
Aug 25Is Qiagen (NYSE:QGEN) Using Too Much Debt?
Jul 28Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$73m |
| Mar 31 2024 | n/a | n/a | US$337m |
| Dec 31 2023 | US$2m | US$979k | US$341m |
| Sep 30 2023 | n/a | n/a | US$485m |
| Jun 30 2023 | n/a | n/a | US$337m |
| Mar 31 2023 | n/a | n/a | US$353m |
| Dec 31 2022 | US$10m | US$950k | US$423m |
| Sep 30 2022 | n/a | n/a | US$488m |
| Jun 30 2022 | n/a | n/a | US$539m |
| Mar 31 2022 | n/a | n/a | US$563m |
| Dec 31 2021 | US$2m | US$900k | US$513m |
| Sep 30 2021 | n/a | n/a | US$311m |
| Jun 30 2021 | n/a | n/a | US$480m |
| Mar 31 2021 | n/a | n/a | US$449m |
| Dec 31 2020 | US$2m | US$900k | US$359m |
| Sep 30 2020 | n/a | n/a | US$191m |
| Jun 30 2020 | n/a | n/a | US$14m |
| Mar 31 2020 | n/a | n/a | -US$31m |
| Dec 31 2019 | US$1m | US$650k | -US$41m |
Compensazione vs Mercato: La retribuzione totale di Thierry ($USD 1.99M ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 8.03M ).
Compensazione vs guadagni: La retribuzione di Thierry è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Thierry Bernard (60 yo)
5.1yrs
Mandato
US$1,991,874
Compensazione
Mr. Thierry Bernard has been Chief Executive Officer of QIAGEN N.V. since March 2020 and also serves as its Member of Management Board since 2021 and had been its Interim Chief Executive Officer since Octo...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Member of Management Board | 5.1yrs | US$1.99m | 0.14% $ 13.5m | |
| CFO, MD & Member of Management Board | 20.8yrs | US$1.07m | 0.19% $ 17.6m | |
| Senior VP & Head of Global Operations | 2.6yrs | Nessun dato | Nessun dato | |
| Vice President of Corporate Communications & Investor Relations | 14.1yrs | Nessun dato | Nessun dato | |
| Senior VP & Head of Human Resources | 5.1yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Life Science Business Area | 6.8yrs | Nessun dato | Nessun dato | |
| Senior Director & Head of External Communications | no data | Nessun dato | Nessun dato | |
| Senior VP & Head of Corporate Strategy and Business Development | 9.5yrs | Nessun dato | Nessun dato | |
| Senior VP & Head of the QIAGEN Digital Insights Business Area | 6.8yrs | Nessun dato | Nessun dato | |
| Senior VP & Head of the Molecular Diagnostics Business Area | no data | Nessun dato | Nessun dato | |
| Senior VP & Head of the Life Sciences Business Area | no data | Nessun dato | Nessun dato |
6.8yrs
Durata media
52yo
Età media
Gestione esperta: Il team dirigenziale di QGEN è esperto e expertise (durata media dell'incarico 6.8 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Independent Member of Supervisory Board | 1.6yrs | US$46.07k | 0.000010% $ 935.6 | |
| Independent Member of the Supervisory Board & Vice Chair of the Scientific Advisory Board | 20.8yrs | US$86.50k | 0.080% $ 7.4m | |
| Independent Member of the Supervisory Board | 13.4yrs | US$101.50k | 0.022% $ 2.0m | |
| Independent Member of the Supervisory Board | 2.4yrs | US$68.50k | Nessun dato | |
| Independent Chairman of Supervisory Board | 11.4yrs | US$188.50k | 0.0067% $ 627.8k | |
| Independent Member of the Supervisory Board | 3.8yrs | US$82.50k | 0.0012% $ 110.4k | |
| Independent Member of the Supervisory Board | 10.4yrs | US$79.50k | 0.0018% $ 172.2k | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Member of the Supervisory Board & Chair of the Scientific Advisory Board | 8.8yrs | US$68.50k | 0.0075% $ 704.5k | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato |
9.6yrs
Durata media
67yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di QGEN sono considerati esperti (durata media dell'incarico 9.6 anni).